...
首页> 外文期刊>Lung cancer: Journal of the International Association for the Study of Lung Cancer >Inhibition of proliferation of human small cell lung cancer cells expressing an autocrine system for gastrin releasing peptide by antisense oligodeoxynucleotides to gastrin releasing peptide receptor.
【24h】

Inhibition of proliferation of human small cell lung cancer cells expressing an autocrine system for gastrin releasing peptide by antisense oligodeoxynucleotides to gastrin releasing peptide receptor.

机译:通过反义寡脱氧核苷酸对胃泌素释放肽受体的表达,抑制表达自分泌系统的胃泌素释放肽的人小细胞肺癌细胞的增殖。

获取原文
获取原文并翻译 | 示例
           

摘要

The objectives of this study were to investigate the effect of antisense (AS) oligodeoxynucleotides (ODNs) directed against gastrin releasing peptide (GRP) receptor mRNA on proliferation of human small cell lung cancer (SCLC) NCI-H345 cells which express the autocrine system for GRP. The methods used were to expose human SCLC cell lines to antisense ODNs or sense ODNs and to measure their proliferation by spectrophotometric assay or viable cell counts. Our results demonstrated that the single or combined AS ODNs against GRP receptor inhibited proliferation of human SCLC NCI-H345 cells significantly by 37% (P<0.01), but did not inhibit proliferation of either human bronchial epithelial BEAS 2B cells or human SCLC NCI-N417 cells, neither of which express the GRP autocrine system. The sense controls did not significantly inhibit proliferation compared with no treatment controls. Specificity was also demonstrated by the observation that cells exposed to AS ODNs had a decrease in GRP receptor expression as measured by specific binding of 34% (P<0.01), and when all three AS ODNs were used, binding was decreased by 60% (P<0.03). Furthermore, AS ODNs decreased by 75% the maximum percentage of cells responding to GRP in an intracellular calcium release assay. Our conclusions are that antisense ODNs directed against a GRP receptor which is involved in an autocrine loop in human SCLC cells inhibited proliferation of these cells by their impact on reducing GRP receptor expression. Further development of means of increasing AS ODN specificity and effectiveness in human SCLC cell is warranted.
机译:这项研究的目的是调查针对胃泌素释放肽(GRP)受体mRNA的反义(AS)寡脱氧核苷酸(ODN)对人小细胞肺癌(SCLC)NCI-H345细胞增殖的影响,该细胞表达自分泌系统GRP。所使用的方法是将人类SCLC细胞系暴露于反义ODN或有义ODN,并通过分光光度法或活细胞计数来测量其增殖。我们的结果表明,针对GRP受体的单一或联合AS ODN可以显着抑制人SCLC NCI-H345细胞的增殖37%(P <0.01),但不抑制人支气管上皮BEAS 2B细胞或人SCLC NCI- N417细胞均不表达GRP自分泌系统。与没有治疗对照相比,有意识对照没有显着抑制增殖。观察到的特异性也证明了暴露于AS ODN的细胞的GRP受体表达降低了34%(P <0.01),并且当使用所有三种AS ODN时,结合降低了60%( P <0.03)。此外,在细胞内钙释放试验中,AS ODNs对GRP作出反应的最大细胞百分比降低了75%。我们的结论是,针对人SCLC细胞中自分泌环的GRP受体的反义ODNs通过降低GRP受体表达而抑制了这些细胞的增殖。保证在人SCLC细胞中增加AS ODN特异性和有效性的手段的进一步发展是必要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号